USA flag logo/image

An Official Website of the United States Government

Photofragmentation MS of Ion Mobility Separated Peptides

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
65515
Program Year/Program:
2005 / SBIR
Agency Tracking Number:
RR017139
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
IONWERKS, INC.
3401 Louisiana St., Suite 355 HOUSTON, TX -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2005
Title: Photofragmentation MS of Ion Mobility Separated Peptides
Agency: HHS
Contract: 2R44RR017139-02
Award Amount: $749,954.00
 

Abstract:

DESCRIPTION (provided by applicant): Ion mobility (IM) is a perfect instrumental platform for slowing and separating peptide ions-this innovation has enabled efficient VUV photofragmentation (IM-oTOFMS/MS) to be demonstrated in phase I. VUV photofragmentation yields a near perfect technology for "on demand" structural fragment ion analysis of complex peptide mixtures especially when combined with the proven capability of IM to distinguish phosphorylated vs. unphosphorylated peptides. In addition, recent internally funded research at lonwerks [34-37] has rather unexpectedly proved the efficacy of incorporating nanoparticulate MALDI matrices into the near surface of biotissues. Recently, lonwerks publications [34-40] and patents [41-44] have established a new approach to molecular microprobe imaging of biotissue surfaces. Thus, the simplification of complex laser microprobe molecular ion spectra from particulate treated biosurfaces is another application which will also benefit from the combination of ion mobility separation followed with on demand photofragmentation structural analysis. Phase II will develop unique IM-oTOFMS/MS hardware using patented multi-pixel position sensitive detectors in a specially designed oTOFMS. Enhanced mass and mobility resolution as well as photofragment MS of this instrument will be tested for applications in proteomics and tissue imaging. Commercialization depends on showing that only IMS-oTOFMS/MS can perform these applications.

Principal Investigator:

Kelley Waters
7135229880
kelldawg@ionwerks.com

Business Contact:


7135229880
Small Business Information at Submission:

Ionwerks, Inc.
Ionwerks, Inc. 2472 Bolsover, Ste 255 Houston, TX 77005

EIN/Tax ID: 760589694
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No